184 related articles for article (PubMed ID: 28478527)
1. Long-Term Abobotulinumtoxin A Treatment of Cervical Dystonia.
Bentivoglio AR; Di Stasio E; Mulas D; Cerbarano ML; Ialongo T; Laurienzo A; Petracca M
Neurotox Res; 2017 Aug; 32(2):291-300. PubMed ID: 28478527
[TBL] [Abstract][Full Text] [Related]
2. Dysport and Botox at a ratio of 2.5:1 units in cervical dystonia: a double-blind, randomized study.
Yun JY; Kim JW; Kim HT; Chung SJ; Kim JM; Cho JW; Lee JY; Lee HN; You S; Oh E; Jeong H; Kim YE; Kim HJ; Lee WY; Jeon BS
Mov Disord; 2015 Feb; 30(2):206-13. PubMed ID: 25476727
[TBL] [Abstract][Full Text] [Related]
3. Treatment of cervical dystonia with abo- and onabotulinumtoxinA: long-term safety and efficacy in daily clinical practice.
Jochim A; Meindl T; Mantel T; Zwirner S; Zech M; Castrop F; Haslinger B
J Neurol; 2019 Aug; 266(8):1879-1886. PubMed ID: 31049731
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of long-term botulinum toxin treatment for acquired cervical dystonia: a 25-year follow-up.
Petracca M; Lo Monaco MR; Ialongo T; Di Stasio E; Cerbarano ML; Maggi L; De Biase A; Di Lazzaro G; Calabresi P; Bentivoglio AR
J Neurol; 2023 Jan; 270(1):340-347. PubMed ID: 36068376
[TBL] [Abstract][Full Text] [Related]
5. A 500 U/2 mL dilution of abobotulinumtoxinA vs. placebo: randomized study in cervical dystonia.
Lew MF; Brashear A; Dashtipour K; Isaacson S; Hauser RA; Maisonobe P; Snyder D; Ondo W
Int J Neurosci; 2018 Jul; 128(7):619-626. PubMed ID: 29343142
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized-controlled trial.
Poewe W; Burbaud P; Castelnovo G; Jost WH; Ceballos-Baumann AO; Banach M; Potulska-Chromik A; Ferreira JJ; Bihari K; Ehler E; Bares M; Dzyak LA; Belova AN; Pham E; Liu WJ; Picaut P
Mov Disord; 2016 Nov; 31(11):1649-1657. PubMed ID: 27653448
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of botulinum neurotoxin type A injections in naïve and previously-treated patients suffering from Torti- or Laterocollis or -caput: Results from a German-Austrian open-label prospective post-marketing surveillance study.
Jost WH; Schramm A; Müngersdorf M; Stenner A; Schwingenschuh P; Maisonobe P; Koch M; Haslinger B
J Neurol Sci; 2019 Apr; 399():44-50. PubMed ID: 30771702
[TBL] [Abstract][Full Text] [Related]
8. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
[TBL] [Abstract][Full Text] [Related]
9. Primary results from the cervical dystonia patient registry for observation of onabotulinumtoxina efficacy (CD PROBE).
Jankovic J; Adler CH; Charles D; Comella C; Stacy M; Schwartz M; Manack Adams A; Brin MF
J Neurol Sci; 2015 Feb; 349(1-2):84-93. PubMed ID: 25595221
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a randomised, double-blind, placebo-controlled study.
Mordin M; Masaquel C; Abbott C; Copley-Merriman C
BMJ Open; 2014 Oct; 4(10):e005150. PubMed ID: 25324317
[TBL] [Abstract][Full Text] [Related]
11. A Retrospective, Single-Center Comparative Cost Analysis of OnabotulinumtoxinA and AbobotulinumtoxinA for Cervical Dystonia Treatment.
Trosch RM; Shillington AC; English ML; Marchese D
J Manag Care Spec Pharm; 2015 Oct; 21(10):854-60. PubMed ID: 26402386
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia.
Truong D; Brodsky M; Lew M; Brashear A; Jankovic J; Molho E; Orlova O; Timerbaeva S;
Parkinsonism Relat Disord; 2010 Jun; 16(5):316-23. PubMed ID: 20359934
[TBL] [Abstract][Full Text] [Related]
13. A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia.
Odergren T; Hjaltason H; Kaakkola S; Solders G; Hanko J; Fehling C; Marttila RJ; Lundh H; Gedin S; Westergren I; Richardson A; Dott C; Cohen H
J Neurol Neurosurg Psychiatry; 1998 Jan; 64(1):6-12. PubMed ID: 9436720
[TBL] [Abstract][Full Text] [Related]
14. Cervical dystonia: factors deteriorating patient satisfaction of long-term treatment with botulinum toxin.
Marciniec M; Szczepańska-Szerej A; Rejdak K
Neurol Res; 2020 Nov; 42(11):987-991. PubMed ID: 32693754
[TBL] [Abstract][Full Text] [Related]
15. A 17-year experience of abobotulinumtoxina in cervical dystonia.
Vivancos-Matellano F; Ybot-Gorrin I; Diez-Tejedor E
Int J Neurosci; 2012 Jul; 122(7):354-7. PubMed ID: 22329596
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia.
Dressler D; Paus S; Seitzinger A; Gebhardt B; Kupsch A
J Neurol Neurosurg Psychiatry; 2013 Sep; 84(9):1014-9. PubMed ID: 23687362
[TBL] [Abstract][Full Text] [Related]
17. Cervical dystonia: clinical and therapeutic features in 85 patients.
Camargo CH; Teive HA; Becker N; Baran MH; Scola RH; Werneck LC
Arq Neuropsiquiatr; 2008 Mar; 66(1):15-21. PubMed ID: 18392407
[TBL] [Abstract][Full Text] [Related]
18. Quality of life in long-term botulinum toxin treatment of cervical dystonia: Results of a cross sectional study.
Moll M; Rosenthal D; Hefter H
Parkinsonism Relat Disord; 2018 Dec; 57():63-67. PubMed ID: 30150129
[TBL] [Abstract][Full Text] [Related]
19. Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy).
Charles PD; Adler CH; Stacy M; Comella C; Jankovic J; Manack Adams A; Schwartz M; Brin MF
J Neurol; 2014 Jul; 261(7):1309-19. PubMed ID: 24752807
[TBL] [Abstract][Full Text] [Related]
20. Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview.
Petracca M; Guidubaldi A; Ricciardi L; Ialongo T; Del Grande A; Mulas D; Di Stasio E; Bentivoglio AR
Toxicon; 2015 Dec; 107(Pt A):129-40. PubMed ID: 26327120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
